NLNº 35EU Policy & Regulation
21st.Bio files EU Novel Food dossier for precision-fermented milk protein
21st.Bio has filed an EU Novel Food application for precision-fermented beta-lactoglobulin after US approval in October 2025, and calls for a fast-track route for nature-identical proteins.
· 3 min at the table

Danish biotech 21st.Bio has filed an EU Novel Food application for bovine beta-lactoglobulin (BLG), a milk protein it produces without animals, months after securing US regulatory approval in October 2025.
The filing, if approved, would allow resource-efficient dairy protein production and sale in Europe at a time when supply constraints continue to squeeze the whey protein market. BLG is the predominant protein in whey protein from milk, valued for its high-quality amino acid profile and versatility across food and beverage applications.
21st.Bio produces the ingredient through precision fermentation, a process that 'trains' microorganisms to make specific targeted ingredients such as high-value proteins in bioreactors. The technology can generate a wide range of traditionally animal-derived ingredients independent of animal agriculture.
Which organism powers the platform?
The company's BLG Essential+ solution uses Aspergillus oryzae, a microorganism applied for centuries in traditional Japanese food fermentation, including soy sauce and miso. The production platform was developed and refined by biotech specialist Novonesis, then licensed and further advanced by 21st.Bio for alternative-protein production at scale.
A 2025 peer-reviewed study in Applied Microbiology and Biotechnology described the strain lineage as the first mycotoxin-free A. oryzae lineage for industrial production of alternative and novel proteins.
José Arnau, chief of strain engineering and regulatory affairs at 21st.Bio and co-author of the study, said: "This is a well-characterised production platform with consumer safety designed into the strain."
He added: "Advanced genome analyses allow regulators to assess safety at strain level with far greater precision, and for proven platforms producing proteins that match those found in nature, the regulatory requirements should be lower and the safety evaluation more straightforward... and faster."
Why is 21st.Bio calling for a fast-track route?
Despite Europe's strong precision fermentation and alternative protein ecosystem, 21st.Bio said preparing a full EU dossier required "years of scientific and procedural work." Subsequent approval processes and timelines make it difficult for companies to plan investments, build facilities and launch products in the region.
The company is calling for a fast-track pathway for "well-characterised, nature-identical" food proteins produced using host strains and technologies with demonstrated records of safe use. It argues this would preserve Europe's high safety standards while giving applicants a clearer timetable.
Thomas G Schmidt, co-founder and CEO of 21st.Bio, said: "Europe has the science, the companies and the industrial heritage in precision fermentation to lead the wave of healthy and nutritious food production."
"What Europe still needs is a home market that allows industrially proven technology to move from laboratories into fermentation factories built in Europe. A predictable, science-based route to market can strengthen food resilience, attract industrial investment and ensure that European innovation is commercialised in Europe," Schmidt said.
What happens next?
The European Food Safety Authority evaluation process now determines the timetable for any EU market entry, with approval gating both European sales of BLG Essential+ and any investment in regional fermentation capacity. Operators in sports nutrition, dairy alternatives and functional beverages should track the dossier's progress as a signal of when fermentation-derived whey proteins could ease current whey supply constraints.
By Elena Vasquez
via FoodBev (Source)
More from Elena Vasquez
Show full bio
News editor covering regulation, policy and their impact on European hospitality industry at Eurotables Report.
155 articles
Other tables tonight
- Nº 10Biospringer by Lesaffre buys ModuMax taste tech from DSM-FirmenichESOctober 30, 2026
- Nº 04Edonia raises €15m to scale microalgae protein ingredient EdoNLOctober 10, 2026
- Nº 41Plant-Based Food Hits $6.6 Billion as Category Outgrows Trend StatusITOctober 30, 2026
- Nº 48SalzburgMilch completes merger with 90% cooperative ownershipITNovember 4, 2026
- Nº 31Tate & Lyle and BioHarvest confirm plant-based sweetener breakthroughNLOctober 12, 2026